Overview

Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
RATIONALE: Bimatoprost ophthalmic solution may help increase eyebrow and eyelash growth in patients who have undergone chemotherapy. PURPOSE: This randomized clinical trial is studying how wells bimatoprost ophthalmic solution works in increasing eyebrow and eyelash growth in patients who have undergone chemotherapy for breast cancer and in healthy participants.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Bimatoprost
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Meets 1 of the following criteria:

- Diagnosis of breast cancer (group 1)

- Completed chemotherapy within the past month that has resulted in eyebrow alopecia or
eyelash hypotrichosis

- Eyebrow score of 0-2 or eyelash score of 0-2 on the study's qualitative eyebrow or
eyelash growth chart

- Has no known underlying disease (group 2)

- Desires thicker, fuller, or more numerous eyebrows

Exclusion criteria

- pregnant

- does not Speak a language adequately covered by study translator services

- cognitive impairment

- history of trauma or burn to the eyebrow region, alopecia areata, or trichotillomania

- known diagnoses possibly underlying or contributing to the state of the eyebrows
including, but not limited to, telogen effluvium or anagen effluvium (group 2)

- active ocular disease (group 1)

- thyroid hormone level abnormalities (group 2)

- More than 2 years since prior ocular surgery (group 1)

- prior topical medication for increasing eyebrow growth within 30 days od starting
study treatment

- concomitant chemotherapy for the treatment of cancer (group 1)

- concomitant therapy for eyelash or eyebrow growth